Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine
<p>Despite progress through expanded use of bed nets and anti-malarial drugs, <em>Plasmodium falciparum</em> (Pf) malaria caused about 200 million cases and 500,000 deaths in 2015. An ideal vaccine would reduce the burden of disease and interrupt transmission. Despite decades of ef...
Hlavní autor: | Ishizuka, A |
---|---|
Další autoři: | Draper, S |
Médium: | Diplomová práce |
Vydáno: |
2016
|
Podobné jednotky
-
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Autor: Bhatia, Sangeeta
Vydáno: (2022) -
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
Autor: Zita Sulyok, a další
Vydáno: (2021-05-01) -
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
Autor: Benjamin Mordmüller, a další
Vydáno: (2022-08-01) -
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
Autor: Drissa Coulibaly, a další
Vydáno: (2022-10-01) -
PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adultsResearch in context
Autor: Anneth Tumbo, a další
Vydáno: (2024-10-01)